This articlemay have been created or edited in return for undisclosed payments, a violation of Wikipedia'sterms of use. It may require cleanup to comply with Wikipedia'scontent policies, particularlyneutral point of view.(September 2021)
Figure 1. A fraction of receptor not bound to ligand in solution is captured by the ligand coated solid phase and subsequently labelled with a fluorescent secondary antibody.
Akinetic exclusion assay (KinExA) is a type ofbioassay in which a solution containingreceptor,ligand, and receptor-ligand complex is briefly exposed to additional ligand immobilized on a solid phase.[1][2]
During the assay, a fraction of the free receptor is captured by the solid phase ligand and subsequently labeled with afluorescent secondary molecule (Figure 1).[1][2] The short contact time with the solid phase does not allow significant dissociation of the pre-formed complexes in the solution.[3] Solution dissociation is thus "kinetically excluded" from contributing to the captured receptor and the resulting signal provides a measure of the free receptor in the solution.
Measuring the free receptor as a function of total ligand in a series of equilibrated solutions enables calculation of the equilibrium dissociation constant (Kd).[1][2][3][4][5][6][7][8] Measuring the free receptor with several points beforeequilibrium enables measurement of the association rate constant (kon). The off rate (koff) can also be directly measured, however it is usually calculated from the measured Kd and measured kon, (koff = Kd * kon).
Figure 2. Example of signal generation. 1) Beads Load. 2) Equilibrated solution passes over column. 3) Introduction of secondary label. 4) Fluorescent emission of captured free receptor.
Because the fluorescent secondary molecule is applied after capture of the free receptor from solution (Figure 2) the binding constants measured using a kinetic exclusion assay are for unmodified molecules in solution and thus more accurately reflectsendogenous binding interactions than methods requiring modification (typically labeling or immobilization) before measurement.[1][2] Kinetic exclusion assays have been performed using unpurified molecules,[4][5] in serum,[7] and have measured binding tocell membrane proteins on intact whole cell[8][11] which brings the measured binding interactions closer to their endogenous state.
Kinetic exclusion assay have also been applied for concentrationimmunoassay, where it has proven capable of providing the maximum theoretical, Kd limited, sensitivity.[28][29] An example of this technique has been employed for sensitive detection ofenvironmental contaminants in near real-time.[30]
A series of samples are prepared with all the same receptor (R) concentration but in which the ligand (L) concentration istitrated. After equilibrium is reached each sample is measured by flowing it through the column (Figure 2).
To measure therate constants, known concentrations of receptor and ligand are mixed in solution and the quantity of free receptor is repeatedly measured over time as the solution phase reaction occurs. The time course of the free receptor depletion is then fit with a standardbimolecular rate equation.
^abcdeBlake, Robert C.; Pavlov, Andrey R.; Blake, Diane A. (1999). "Automated Kinetic Exclusion Assays to Quantify Protein Binding Interactions in Homogeneous Solution".Analytical Biochemistry.272 (2):123–134.doi:10.1006/abio.1999.4176.PMID10415080.
^abGlass, Thomas R.; Winzor, Donald J. (2014). "Confirmation of the validity of the current characterization of immunochemical reactions by kinetic exclusion assay".Analytical Biochemistry.456:38–42.doi:10.1016/j.ab.2014.04.011.PMID24751468.
^abcRathanaswami, Palaniswami; Richmond, Karen; Manchulenko, Kathy; Foltz, Ian N. (2011-07-01). "Kinetic analysis of unpurified native antigens available in very low quantities and concentrations".Analytical Biochemistry.414 (1):7–13.doi:10.1016/j.ab.2011.02.034.ISSN1096-0309.PMID21371417.
^abcLuginbühl, Béatrice; Kanyo, Zoltan; Jones, R. Mark; Fletterick, Robert J.; Prusiner, Stanley B.; Cohen, Fred E.; Williamson, R. Anthony; Burton, Dennis R.; Plückthun, Andreas (2006-10-13). "Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation".Journal of Molecular Biology.363 (1):75–97.doi:10.1016/j.jmb.2006.07.027.ISSN0022-2836.PMID16962610.
^Xie, Lei; Mark Jones, R.; Glass, Thomas R.; Navoa, Ryman; Wang, Yan; Grace, Michael J. (2005). "Measurement of the functional affinity constant of a monoclonal antibody for cell surface receptors using kinetic exclusion fluorescence immunoassay".Journal of Immunological Methods.304 (1–2):1–14.doi:10.1016/j.jim.2005.04.009.ISSN0022-1759.PMID16098983.
^Tabrizi, Mohammad A.; Bornstein, Gadi Gazit; Klakamp, Scott L.; Drake, Andrew; Knight, Richard; Roskos, Lorin (2009). "Translational strategies for development of monoclonal antibodies from discovery to the clinic".Drug Discovery Today.14 (5–6):298–305.doi:10.1016/j.drudis.2008.12.008.ISSN1359-6446.PMID19152840.
^Chiu, Y. W.; Li, Q. X.; Karu, A. E. (2001-11-15). "Selective binding of polychlorinated biphenyl congeners by a monoclonal antibody: analysis by kinetic exclusion fluorescence immunoassay".Analytical Chemistry.73 (22):5477–5484.doi:10.1021/ac0102462.ISSN0003-2700.PMID11816577.
^Glass, Thomas R.; Ohmura, Naoya; Saiki, Hiroshi (2007-03-01). "Least detectable concentration and dynamic range of three immunoassay systems using the same antibody".Analytical Chemistry.79 (5):1954–1960.doi:10.1021/ac061288z.ISSN0003-2700.PMID17256970.